ADC Toxicity Summit Hyatt Regency Boston, Boston

There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing a narrow therapeutic index. Understanding the causes of toxicity, their translatability into the clinic, as well as mitigation and dosing strategies to limit these toxicities will enable ADC developers to take more assets into the clinic while reducing the costs of failures.

The first-of-its-kind ADC Toxicity Summit will allow companies developing ADCs to overcome toxicological related challenges, by hearing case-study-led presentations on approved ADCs, including ImmunoGen’s Mirvetuximab Soravtansine, as well as important scientific and strategic discussions. Designed to provide you with the toolkit to design and deliver more tolerable ADCs to patients without lowering efficacy this is your exclusive opportunity to join peers with expertise in toxicology, safety, and pathology.

The ADC Toxicity Summit is your perfect platform to overcome where others have failed and accelerate more ADCs through preclinical development into the clinic and to market.

⌛ Event Dates & Venue

25 Jul - 27 Jul 2023, 9:00 am - 5:00 pm

💸 Website & Tickets

Go to Event Website
Event Hashtag:
Ticket Pricing:
FULL PACKAGE: Conference + Workshop Day - Drug Developer: USD 4097.00, Conference Only - Drug Developer: USD 2999.00, FULL PACKAGE: Conference + Workshop Day - Solution Provider: USD 5297.00, Conference Only - Solution Provider: USD 3799.00

◑ Topics | Categories